The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which ...

Semaglutide improved maximum walking distance in patients with type 2 diabetes and symptomatic peripheral artery disease.

A doctor has warned of the potential dangers of a 'game changing' diabetes drug which could rival the likes of Ozempic. The ...

Doctors are learning more about the wider effects of the injections, from lowering blood pressure to helping people quit ...

New Delhi: Torrent Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...